Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 73

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 73
---
 or other downstream vendors,
are potentially vulnerable to damage from malicious intrusion, malware, computer viruses, unauthorized access, natural disasters, terrorism,
war and telecommunication and electrical failures. While NewGenIvf is not aware that it has experienced any such system failure, accident
or security breach to date, if such an event were to occur and cause interruptions in its operations, it could result in a material disruption
to its ability to operate and deliver its solutions. In addition, to the extent that any disruption or security breach were to result
in a loss or inappropriate disclosure of confidential information, NewGenIvf could incur liability. See “—Risks Related to Government Regulation — NewGenIvf operates in a highly regulated industry and must comply with a significant number of complex and evolving requirements. Any lack of requisite approvals, licenses, or permits applicable to NewGenIvf’s business may have a material and adverse impact on NewGenIvf’s business, financial condition, and results of operations — Data Protection and Breaches.”

<div align='center'>41</div>

Risks Related to NewGenIvf’s Relationships with Third Parties

NewGenIvf’s business depends on its ability to maintain its network of high-quality fertility specialists and other healthcare providers. If NewGenIvf is unable to do so, its future growth would be limited and its business, financial condition and results of operations would be harmed.

NewGenIvf’s performance
and success is dependent upon its continued ability to maintain a credentialed network of high-quality fertility specialists, including
its senior management team, other key employees, as well as research and development and operation maintenance personnel, many of whom
are difficult to replace. Fertility specialists could refuse to contract, demand higher payments or take other actions that could result
in higher medical costs, less attractive service for its clients or difficulty meeting regulatory or accreditation requirements. Identifying
high-quality fertility specialists, credentialing and negotiating contracts with them and evaluating, monitoring and maintaining its network,
requires significant time and resources. Competition in the healthcare industry for qualified employees is intense. NewGenIvf may need
to offer higher compensation and other benefits in order to attract and retain key personnel in the future, which could increase NewGenIvf’s
compensation expenses, including stock-based compensation. NewGenIvf’s continued ability to compete effectively depends on NewGenIvf’s
ability to attract new employees and to retain and motivate NewGenIvf’s existing employees. If NewGenIvf is not successful in